Part of SRM Group of Institutions

  • Get Connected
  • Get Social

Dr. Manoj Kumar Yadav

Associate Professor
Department of Biomedical Engineering

[email protected]

Education

Degree Specialization University/Institute Name, Year
Ph.D. Bioinformatics Banaras Hindu University, 2013
M.Sc Bioinformatics University Of Allahabad, 2006
B.Sc Chemistry, Botany, Zoology University Of Allahabad, 2004

Research Interests

  • Application of Machine Learning, Artificial Intelligence and Data Science in solving Breast cancer related research problems
  • Identification of potent drug targets and inhibitor designing using Computational methods
  • Study of Macro-molecular interactions using Computer-Aided Drug Design and Molecular Dynamics Simulation  

Current Courses Taught / Teaching Interest

  • AI and ML in Biological Sciences (MSBM209)
  • Introduction Bioinformatics and Computational Biology (MSBM106)
  • Biostatistics (MSBM203)
  • Introduction to MATLAB (CS1309)
  • Medical-Informatics (BI0401)
  • PERL Programming and BioPERL (BI 0302)
  • Cheminformatics and Drug Design (BT0302)

Academic Experience / Industrial Experience

  • Thorough Academician and Researcher with over 15 years of experience and held positions in Department of Bioinformatics, Biotechnology, Medical Biotechnology in Banaras Hindu University, Varanasi, Pt J N M Government Medical College, Raipur etc.
  • Associated with SRM University, Delhi-NCR, Sonipat since 2018.

Achievements / Awards / Recognitions

  • Received SBBS Distinguished Scientist Awardfor the year 2024 from the Society for Bioinformatics and Biological Sciences
  • Honorary “Fellow of Society of Life Sciences(S.L.Sc.)” from National Society of Life Sciences, India
  • Qualified National Eligibility Test (NET) in June-2008 and December-2009
  • QualifiedGraduate Aptitude Test in Engineering (GATE)-2009
  • Member of editorial board and Reviewer of many peer reviewed journals

R&D / Industrial Projects

  • Received seed money from SRMUH as Principal Investigator on "Integrated in silico and in vitro study of novel aromatase inhibitors for Breast Cancer treatment". Status: Ongoing
  • Principal Investigator of a research project funded by the Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, entitled "Drug repurposing against key COVID-19 drug targets using advanced Machine Learning-based algorithms", awarded in 2020. Status: Completed
  • Extramural research project from the Indian Council of Medical Research (ICMR) entitled "Searching for new antimalarial drugs: In-silico identification and characterization of drug targets and designing lead compounds against identified targets". Duration: 3 years (November 2011 – March 2014). Status: Completed

Selected Publications/Working Papers

  • K. Bhutani, P. Yadav, S. Vishwakarma, M.K. Yadav (2025), “The current landscape of aromatase inhibitors for the treatment of estrogen receptor-positive breast carcinoma”, J Steroid Biochem Mol Biol., 250: 106729 https://doi.org/10.1016/j.jsbmb.2025.106729
  • M.K. Yadav, V. Dahiya, M.K. Tripathi, N. Chaturvedi, M. Rashmi, A. Ghosh, V.S. Raj (2024) “Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery” Eur J Pharmacol, 985. https://doi.org/10.1016/j.ejphar.2024.177103
  • P. Yadav, M.K. Tripathi, M.K. Yadav (2024) “Structure-guided identification of novel aromatase inhibitors targeting breast carcinoma”, Chemistry & biodiversity, 21(11), e202401465. https://doi.org/10.1002/cbdv.202401465 21(11):e202401465
  • A.A. Shah, S. Ahmad, M.K. Yadav, K. Raza, M.A. Kamal, S. Akhtar (2024) “Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis,” Curr Med Chem. 31(5):595-619
  • R. Tyagi, A. Paul, V. S. Raj, K. K. Ojha, M. K. Yadav (2023), “A Drug Repurposing Approach to Identify Therapeutics by Screening Medicines for Malaria Ventures Exploiting SARS-CoV-2 Main Protease,” Chemistry and Biodiversity, 20(2), e202200600.
  • M.K. Yadav, S. Ahmad, K. Raza M. Eswaran, M. Pasha KM (2022) “Predictive modeling and therapeutic repurposing of natural compounds against receptor-binding domain of SARS-CoV-2,” J. Biomol. Struct. Dyn, 2022, 1-13. doi:10.1080/07391102.2021.2021993.
  • Y. Jha, B. Dehury, S.P.J. Kumar, A. Chaurasia, U.B. Singh, M.K. Yadav, U.B. Angadi, R. Ranjan, R.B. Subramanian, M. Tripathy, S. Kumar (2021) “Delineation of molecular interactions of PGPR induced β-1,3-glucanases and guanosine triphosphate (GTP) ligand for antifungal response in rice,” Mol Biol Rep., 2021 doi:10.1007/s11033-021-07059-5.
  • M. K. Yadav, M. K. Tripathi, S. Yadav, “Discovery of novel inhibitors targeting Plasmodium knowlesi Dihydrofolate Reductase using molecular docking and molecular dynamics simulation,” Molecular Pathogenesis, 2021 161:1:14, doi: 10.1016/j.micpath.2021.105214.
  • A. Choubey, K. Girdhar, A. K. Kar, S. Kushwaha, M. K. Yadav, D. Ghosh, P. Mondal, “Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia,” J. Biol. Chem., 2020, doi: 10.1074/jbc.RA120.013484.
  • M. K. Yadav, R. R. Bharti, and M. Rashmi, “Exploration and identification of novel inhibitors against Knowpain-4 of P. knowlesi using a combinatorial 3D pharmacophore modeling approach,” Netw. Model. Anal. Heal. Informatics Bioinforma., vol. 9, no. 1, 2020, doi: 10.1007/s13721-020-00273-4.
  • P. Mishra, L. Samanta, S. Jena, S. S. Swain, S. Kumar, M. K. Yadav, B. Paital., “Possible activation of NRF2 by Vitamin E/Curcumin against altered thyroid hormone induced oxidative stress via NFĸB/AKT/mTOR/KEAP1 signalling in rat heart,” Sci. Rep., 2019, doi: 10.1038/s41598-019-43320-5.
  • S. Gajbhiye, P. K. Patra, and M. K. Yadav, “New insights into the factors affecting synonymous codon usage in human infecting Plasmodium species,” Acta Tropica. 2017, doi: 10.1016/j.actatropica.2017.07.025.
  • A. Sahu, P. K. Patra, M. K. Yadav, and M. Varma, “Identification and characterization of ErbB4 kinase inhibitors for effective breast cancer therapy,” J. Recept. Signal Transduct., 2017, doi: 10.1080/10799893.2017.1342129.
  • M. Rashmi, M. K. Yadav, and D. Swati (2017), “Targeting Pyrimidine Pathway of Plasmodium knowlesi: New Strategies Towards Identification of Novel Antimalarial Chemotherapeutic Agents,” Comb. Chem. High Throughput Screen., doi: 10.2174/1386207320666170315123044.
  • M. K. Yadav and D. Swati, “In Silico Study of Variable Surface Proteins in Plasmodium Species: Perspectives in Drug Design,” Interdiscip. Sci. Comput. Life Sci., vol. 8, no. 3, pp. 294–302, 2016, doi: 10.1007/s12539-015-0283-8.
  • M. K. Yadav, A. Singh, and D. Swati, “A Knowledge-Based Approach for Identification of Drugs Against Vivapain-2 Protein of Plasmodium vivax Through Pharmacophore-Based Virtual Screening with Comparative Modelling,” Appl. Biochem. Biotechnol., vol. 173, no. 8, pp. 2174–2188, 2014, doi: 10.1007/s12010-014-1023-y.
  • R. Dubey, P. Singh, A. Kumar, M. K. Yadav, D. Swati, M. Vinayak, A. K. Tewari, “Polymorphic Signature of the Anti-inflammatory Activity of 2,2′-{[1,2-Phenylenebis (methylene)]bis(sulfanediyl)}bis(4,6-dimethylnicotinonitrile),” Cryst. Growth Des., vol. 14, no. 3, pp. 1347–1356, Mar. 2014, doi: 10.1021/cg401842y.
  • M. K. Yadav, S. K. Pandey, and D. Swati, “Drug target prioritization in Plasmodium Falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach,” J. Bioinform. Comput. Biol., 2013, doi: 10.1142/S0219720013500030.
  • M. K. Yadav and D. Swati, “Comparative genome analysis of six malarial parasites using codon usage bias based  tools.,” Bioinformation, vol. 8, no. 24, pp. 1230–1239, 2012, doi: 10.6026/97320630081230.
Back to faculty
Increase Text Decrease Text Dark Mode Light Mode Reset